The impact of lncRNA-GAS5/miRNA-200/ACE2 molecular pathway on the severity of COVID-19
| dc.Affiliation | October university for modern sciences and Arts MSA | |
| dc.contributor.author | Ayeldeen, Ghada | |
| dc.contributor.author | Shaker, Olfat G | |
| dc.contributor.author | Amer, Eman | |
| dc.contributor.author | Zaafan, Mai A | |
| dc.contributor.author | Herzalla, Mohamed R | |
| dc.contributor.author | Keshk, Mofida A | |
| dc.contributor.author | Abdelhamid, Amr M | |
| dc.date.accessioned | 2023-05-20T05:39:26Z | |
| dc.date.available | 2023-05-20T05:39:26Z | |
| dc.date.issued | 2023-05 | |
| dc.description.abstract | was reported to be overexpressed and its targeted ACE2 was down-regulated. The ROC curve was drawn to examine the diagnostic abilities of GAS5, miR-200, and ACE2, yielding high diagnostic accuracy with high sensitivity and specificity. Conclusion: lncRNA-GAS5, miRNA-200, and ACE2 panels presented great diagnostic potential as they demonstrated the highest diagnostic accuracy for discriminating moderate COVID-19 and severe COVID-19 cases. : | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=23488&tip=sid&clean=0 | |
| dc.identifier.doi | https://doi.org/10.2174/0929867330666230515144133 | |
| dc.identifier.other | 10.2174/0929867330666230515144133 | |
| dc.identifier.uri | http://repository.msa.edu.eg/xmlui/handle/123456789/5577 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Bentham Science Publishers B.V. | en_US |
| dc.relation.ispartofseries | Current Medicinal Chemistry; | |
| dc.subject | COVID-19 patients, | en_US |
| dc.subject | miRNA-200, | en_US |
| dc.subject | ACE2, | en_US |
| dc.subject | Lnc-GAS5, | en_US |
| dc.subject | COVID-19 severity, | en_US |
| dc.subject | COVID-19 comorbidities | en_US |
| dc.title | The impact of lncRNA-GAS5/miRNA-200/ACE2 molecular pathway on the severity of COVID-19 | en_US |
| dc.type | Article | en_US |